Exocure Sweden AB
Exocure pioneers exosome biotechnology for advanced cancer therapeutics.
Oversigt
- Ukendt
- Medarbejdere
- Ukendt
- Omsætning
- 2023
- Grundlagt
Nøglebeslutningstagere
Helena Lundquist
Board Member
Magnus Käll
CFO
Jan Lötvall
Founder and Board Member
Mats Persson
Chairman of the Board
+6 flere kontakter i Funnelfeedr
Beskrivelse
Exocure Sweden AB is an innovative biotechnology company focused on harnessing the potential of exosomes for therapeutic applications. They operate as a platform company, developing proprietary technology and methods to manipulate and manufacture these extracellular vesicles. The core mission is to...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Tillverkning av läkemedel
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559427656901
Beslutningstagere
10 kontakter i FunnelfeedrHelena Lundquist
Board Member
Magnus Käll
CFO
Jan Lötvall
Founder and Board Member
Mats Persson
Chairman of the Board
Richard Bergström
Board Member
Klementina Österberg
Alternate Board Member
Søren Melsing
CEO
Catharina Gustafsson Wallich
Board Member
Andre kontakter
Kyong-su Park
Senior Scientist
Roger Olofsson Bagge
Scientific Advisor
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Isofol Medical AB (publ)
10–19 medarbejdereDeveloping next-generation folate drug to improve cancer treatment efficacy.
AcroPharma AB (publ)
0 medarbejdereDeveloping innovative preventive therapeutics for major human diseases.
LIDDS AB
1–4 medarbejdereSwedish drug delivery company utilizing proprietary NanoZolid technology platform.
NeoTargets AB
1 medarbejdereIdentifying curative cancer targets using a proprietary discovery platform.
Theralia AB
0 medarbejderePioneering biotech revolutionizing drug delivery via TOUCAN technology.
Udforsk mere
Spørgsmål om Exocure Sweden AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo